Register | Forgot password?
Switch to Arabic
Thursday, November 26 - 2009

One in three Gulf residents suffers from Arthritis, Pfizer reports

  • United Arab Emirates: Tuesday, December 23 - 2008 at 11:33
  • PRESS RELEASE

More than one in three Gulf residents suffers from chronic arthritic joint pain, with the prevalence of the condition increasing from 30% in 45 year olds to 60% in 65 year olds, according to medical experts in the region.

Article continues below
 
Osteoarthritis is the most common form of arthritis and begins with the breakdown of joint cartilage resulting in pain and stiffness, usually in the fingers, knees, hips, and spine.

But unlike other forms of arthritis which typically affect older people, a rare but severely punishing arthritic condition known as Ankylosing Spondylitis usually strikes between the ages of 17 and 35.

Dr. Walaa Al Asuity, Consultant Orthopedic Spine Surgeon at Gulf Diagnostic Center, Abu Dhabi UAE, said:
"One of the main challenges with treating this severe, chronic, and debilitating form of arthritis is the limited treatment choices."


Relieving pain, improving mobility, and minimizing disability typically begins with the most appropriate pain management medication recommended from a doctor.

Ankylosing Spondylitis is a form of arthritis that primarily affects the spine, causing inflammation that can lead to intense pain and stiffness in the shoulders, knees, hips, ribs and feet. In severe cases, it can cause the spine to fuse together.

With its early onset and progressively damaging effects on the joints, Ankylosing Spondylitis poses a significant burden on patients and their families.

"The inflammation associated with Ankylosing Spondilitis can cause such severe pain that people who suffer from this condition - often young men - cannot perform simple, everyday activities like walking and may have trouble attending school or work," said Prof. Yosri Al Hawari, Consultant Orthopaedic Spine Surgeon, Head of Spinal Surgery Department, Faculty of Medicine, Cairo University.
Also consider reading:
Log in to request more information from Pfizer

Notes and media contacts

Pfizer: Working Together for a Healthier World

Founded in 1849, Pfizer is the world's largest research-based pharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support. At Pfizer, 85,000 colleagues in more than 150 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide.

For more information, please contact:

Lucy Hambour
Wallis Marketing Consultants
P.O. Box 502281
Dubai, United Arab Emirates
Tel: +971 4 390 1950
Fax: +971 4 367 2800

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions